DOKTER GILIO
ActiveSummary
DOKTER GILIO has been active since 2007 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €618k and a net result of €163k. Equity is growing by ~37.9% per year across the filed fiscal years. Its solvency ranks better than 81% of 2331 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
93
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability98▼-2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €55k at 30 days acceptable
Liquidity ample (current ratio 16.99 against 10.28 in 2024; short-term debt: 5.4% and cash: 20.8% of total assets), and 12.2% of the assets are financed with debt.
Credit check for your own amount and term
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
87.8%
Return on assets
23.1%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 30-12-2025 was due by 30-07-2026 and was filed on 30-07-2026, 0 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
on the day
2024
on the day
2023
1 d early
2022
4 d early
2021
1 d early
2020
3 d late
2019
38 d early
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-12-2026 and is due by 30-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today30-12-2026 close30-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€618k▲ 35.8%
2024 · €455k
2018: €66k
2019: €71k
2020: €88k
2021: €173k
2022: €276k
2023: €330k
2024: €455k
2018 → 2025
Total assets
€704k▲ 27.7%
2024 · €551k
2018: €220k
2019: €253k
2020: €239k
2021: €296k
2022: €350k
2023: €418k
2024: €551k
2018 → 2025
Net result
€163k▲ 19.5%
2024 · €136k
2018: €32k
2019: €50k
2020: €62k
2021: €85k
2022: €102k
2023: €91k
2024: €136k
2018 → 2025
Working capital
€611k▲ 36.1%
2024 · €449k
2018: €77k
2019: €118k
2020: €120k
2021: €202k
2022: €312k
2023: €311k
2024: €449k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€173k-€276k▲ 59.1%€330k▲ 19.7%€455k▲ 37.8%€618k▲ 35.8%
Operating result€121k-€151k▲ 25.1%€135k▼ 10.7%€197k▲ 45.6%€229k▲ 16.5%
Net result€85k-€102k▲ 20.2%€91k▼ 11.5%€136k▲ 50.0%€163k▲ 19.5%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 16% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €704k
Fixed assets
€54k ▲ 1.2%
Current assets
€649k ▲ 30.5%
Equity and liabilities €704k
Equity
€618k ▲ 35.8%
Provisions
€48k =
Debt
€38k ▼ 21.0%
Debt's share of the balance-sheet total falls from 8.8% to 5.4%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€244k▲
2024 · €211k
Cash flow
€178k▲
2024 · €151k
Current ratio
16.99▲
2024 · 10.28
Debt to equity
0.06▼
2024 · 0.11
ROE
26.3%▼
2024 · 29.9%
ROA
23.1%▼
2024 · 24.7%
Interest coverage
1602.24▼
2024 · 6728.40
Debt ≤ 1 year
€38k▼
2024 · €48k
Income taxes
€82k▲
2024 · €70k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 50 lines
Balance sheet
Code20242025
Assets
Total assets20/58€551k€704k▲
Formation expenses20€0€0=
Fixed assets21/28€54k€54k▲
Intangible fixed assets21€0€0=
Tangible fixed assets22/27€54k€54k▲
Plant, machinery and equipment23€2k€881▼
Furniture and vehicles24€44k€34k▼
Other tangible fixed assets26€8k€20k▲
Current assets29/58€497k€649k▲
Amounts receivable after more than one year29€200k€200k=
Other amounts receivable291€200k€200k=
Amounts receivable within one year40/41€130k€270k▲
Trade receivables40-€6k
Other amounts receivable41€130k€264k▲
Cash at bank and in hand54/58€140k€146k▲
Deferred charges and accrued income490/1€27k€33k▲
Equity and liabilities
Total equity and liabilities10/49€551k€704k▲
Equity10/15€455k€618k▲
Contributions10/11€20k€20k=
Reserves13€435k€598k▲
Distributable reserves133€435k€598k▲
Provisions and deferred taxes16€48k€48k=
Provisions for liabilities and charges160/5€48k€48k=
Pensions and similar obligations160€48k€48k=
Amounts payable17/49€48k€38k▼
Amounts payable within one year42/48€48k€38k▼
Trade debts44€7k€12k▲
Suppliers440/4€7k€12k▲
Taxes, remuneration and social security45€10k€1k▼
Taxes450/3€10k€1k▼
Other amounts payable47/48€31k€25k▼
Income statement
Code20242025
Non-recurring operating income76A€1k-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€14k€15k▲
Other operating charges640/8€2k€5k▲
Gross operating margin9900€213k€249k▲
Operating profit (loss)9901€197k€229k▲
Financial income75/76B€10k€15k▲
Recurring financial income75€10k€15k▲
Financial charges65/66B€31€152▲
Recurring financial charges65€31€152▲
Profit (loss) for the period before taxes9903€206k€244k▲
Income taxes67/77€70k€82k▲
Profit (loss) for the period9904€136k€163k▲
Profit (loss) for the period to be appropriated9905€136k€163k▲
Appropriation of the result
Profit (loss) to be appropriated9906€136k€163k▲
Transfer from equity791/2€11k-
Transfer to equity691/2€136k€163k▲
To other reserves6921€136k€163k▲
Profit to be distributed694/7€11k-
Return on contributions (dividend)694€11k-
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
30-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
30-12
Financial
Highest result since 2018net €163k ▲19.5%
Operating result €229k, net result €163k, both a record.
30-12
Financial
Equity above €500kEq €618k ▲35.8%
8 profitable years in a row build equity to €618k.
30-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
29-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
26-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-12
Financial
Liquidity quadruplescurrent ratio 13.64
Current ratio from 3.70 to 13.64; short-term debt falls from €75k to €25k.
30-12
Financial
Equity above €200kEq €276k ▲59.1%
5 profitable years in a row build equity to €276k.
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-12
Financial
Equity above €150kEq €173k ▲96.8%
4 profitable years in a row build equity to €173k.
02-08
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema · 3 days late
2020
22-06
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema
Show earlier events
2019
31-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema · 1 day late
2018
31-07
NBB filing
Annual accounts filed
fiscal year 2017 · abbreviated schema · 1 day late
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Maasmechelen
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Ringlaan(M) 863630 MaasmechelenGround area
1,122 m²
Building footprint
250 m²
Volume, LiDAR
1,442 m³
Parcel 73048C1887/00H000, Flanders · tallest building 9.3 m, ±2 floors. Linked by address, not a title deed.
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 73048C1887/00H000 | Flanders | 1,122 m² | 1 · 250 m² | 9.2 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
TTS
BE 0671.792.997
Lasne · Eq €617,518
CLAESSENS ENDOCRINOLOGIE
BE 0648.777.966
Léglise · Eq €617,466
Dr MARIUS An, huisarts
BE 0836.563.335
Ronse · Eq €617,234
Dr. DOBBELAERE SABINE
BE 0862.262.001
Boechout · Eq €617,073
Dr. Van Imschoot Bart, gastro-enterologie
BE 0845.605.121
Maarkedal · Eq €616,835
Of 16,627 companies in sector 86220 we hold annual accounts for 7,974. 6,261 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded29-09-2007
Fiscal year end30-12
Activities, NACEBEL 2025
86220Specialist medical practice
86910Medical imaging and medical laboratories
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.